A medical elaboration on von Willebrand disease with its dental management

被引:1
作者
Aparna, M. [1 ,2 ]
机构
[1] Govt Dent Coll, Dept Oral Med & Radiol, Dent Coll Bldg,Dent Coll Rd,Med Coll Campus, Kozhikode 673008, Kerala, India
[2] Padmasree House, Kozhikode 673016, Kerala, India
关键词
von Willebrand disease; Bleeding disorder; Dental management;
D O I
10.1016/j.ajoms.2016.06.005
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: von Willebrand disease (vWD) is the most common type of autosomally inherited bleeding disorder representing a range of quantitative and qualitative pathologies of the adhesive glycoprotein, von Willebrand factor (vWF). Since symptoms are often mild, a significant majority of patients remain undiagnosed. Method: A review from the literature which imparts the knowledge on background, pathophysiology, classification, diagnostic measures and treatment modalities of this fatal bleeding disorder. Results: With all forms of vWD, however, bleeding episodes can be severe and may require treatment. Conclusions: A primary care physician should play a role in recognizing the signs and symptoms of vWD and in referring patients for proper management. The treatment of bleeding in vWD involves the use of desmopressin and plasma-derived vWF concentrates and a variety of adjunctive agents. (C) 2016 Asian AOMS, ASOMP, JSOP, JSOMS, JSOM, and JAMI. Published by Elsevier Ltd. All rights reserved.(star)
引用
收藏
页码:442 / 445
页数:4
相关论文
共 29 条
[1]   Oral contraceptives and DDAVP nasal spray: Patterns of use in managing vWD-associated menorrhagia - A single-institution study [J].
Amesse, LS ;
Pfaff-Amesse, T ;
Leonardi, R ;
Uddin, D ;
French, JA .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (07) :357-363
[2]   FACTOR-VIII-C INCREASES AFTER DESMOPRESSIN IN A SUBGROUP OF PATIENTS WITH AUTOSOMAL RECESSIVE SEVERE VON-WILLEBRAND DISEASE [J].
CASTAMAN, G ;
LATTUADA, A ;
MANNUCCI, PM ;
RODEGHIERO, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) :147-151
[3]   von Willebrand factor to the rescue [J].
De Meyer, Simon F. ;
Deckmyn, Hans ;
Vanhoorelbeke, Karen .
BLOOD, 2009, 113 (21) :5049-5057
[4]  
Dobrkovska A, 1998, HAEMOPHILIA, V4, P33
[5]  
Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345
[6]  
Federici AB, 2000, HAEMOPHILIA, V6, P71
[7]   Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP [J].
Kaufmann, JE ;
Oksche, A ;
Wollheim, CB ;
Günther, G ;
Rosenthal, W ;
Vischer, UM .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :107-116
[8]  
Lee JW, 2005, INT ANESTHESIOL CLIN, V43, P55, DOI 10.1097/01.aia.0000157488.44607.2c
[9]  
LETHAGEN S, 1987, THROMB HAEMOSTASIS, V58, P1033
[10]   von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy [J].
Lillicrap, David .
BLOOD, 2013, 122 (23) :3735-3740